Correction of intraoperative coagulopathy in a patient with neurofibromatosis type I with intravenous desmopressin (DDAVP).
A patient with the genetic condition neurofibromatosis type I and no known coagulopathy undergoing cesarean delivery, had diffuse uterine and surgical site bleeding that was not correctable by oxytocin, methylergonovine and PGF2 alpha. Despite good uterine tone, hemorrhage continued from the uterus and the surrounding tissues, persisting even after surgical ligation of the uterine arteries. With no change in her condition, which was behaving clinically as a coagulopathy, an infusion of desmopressin acetate (DDAVP) was begun. The patient's bleeding promptly resolved shortly after infusion of this agent. A review of relevant literature suggests that platelet reactivity of patients with neurofibromatosis type 1 is attenuated in some in vitro conditions. Thus, there may be some theoretical basis for using DDAVP in patients with neurofibromatosis type 1 who have bleeding problems with no other known source, such as in the case presented here.
Lighthall
G K
GK
Department of Anesthesia, Stanford University School of Medicine, Stanford, CA, USA. geoffl@stanford.edu
Morgan
C
C
Cohen
S E
SE
D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000188:drug therapy*; D002585:Cesarean Section; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006400:Hematocrit; D006801:Humans; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D007431:Intraoperative Complications / Q000097:blood* / Q000188:drug therapy*; D009456:Neurofibromatosis 1 / Q000150:complications*; D007744:Obstetric Labor Complications / Q000097:blood* / Q000188:drug therapy*; D011247:Pregnancy; D014592:Uterine Hemorrhage / Q000150:complications / Q000628:therapy
D000925:Anticoagulants; D003894:Deamino Arginine Vasopressin